Who’s Hired? Former Hikma Chief Olafsson Takes Lead At Mallinckrodt
As Teva Names New Global R&D And Chief Medical Officer
Siggi Olafsson has taken the reins at Mallinckrodt after stepping down as Hikma’s CEO. At the same time, Teva has named a new global R&D and chief medical officer while Piramal Pharma Solutions has appointed a fresh COO and Formycon has added to its supervisory board.
You may also be interested in...
Hikma Could Consider Exit Strategy For Generics Business
Hikma says all options are on the table for its beleaguered generics business, with an immediate sale unlikely but the door open for a longer-term exit strategy. Meanwhile, the firm has also offered an update on recruitment for a new CEO.
2022 Hires Reflect Global Challenges And Opportunities
Executive changes in 2022 reveal how the industry is adjusting to a volatile post-COVID environment.
Alvotech Switches CEO And Takes COO From Teva
Major leadership changes are being made at the top of Alvotech, with founder Robert Wessman stepping in to replace Mark Levick as CEO at the same time as Teva’s former head of global R&D, Hafrun Fridriksdottir, becomes COO of the biosimilars developer.